On the other hand, in the study of Faber and colleagues, inhibition of PI3K/mTOR signalling in non-small cell lung cancers with activating mutations of EGFR did not induce apoptosis, in contrast to HER2-amplified breast tumours in which sensitivity was seen [140]. The gene discussed is EGFR; the disease is breast neoplasm.